Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia

被引:62
作者
Rijneveld, Anita W.
Weijer, Sebastiaan
Bresser, Paul
Florquin, Sandrine
Vlasuk, George P.
Rote, William E.
Spek, C. Arnold
Reitsma, Pieter H.
van der Zee, Jaring S.
Levi, Marcel
van der Poll, Tom
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[6] Corvas Int, San Diego, CA USA
关键词
coagulation; tissue factor; pneumonia; lung; Streptococcus pneumoniae; mice;
D O I
10.1097/01.CCM.0000218807.20570.C2
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The tissue factor (TF)-factor Vila (FVIIa) complex not only is essential for activation of blood coagulation but also affect the inflammatory response during sepsis. The objective of this study was to determine the role of TF-FVIIa in pneumonia caused by Streptiococcus pneumoniae, the most important causative organism in community-acquired pneumonia and a major cause of sepsis. Design: A controlled, in vivo laboratory study. Setting: Research laboratory of a health sciences university. Patients and Subjects., Patients with unilateral community-acquired pneumonia and female BALB/c mice. Interventions. Bilateral bronchoalveolar lavage was performed in patents with community-acquired pneumonia. In mice, pneumonia was induced by intranasal inoculation with S. pneumoniae with or without concurrent inhibition of TF-FVIIa by subcutaneous injections of recombinant nematode anticoagulant protein (rNAPc2). Measurements and Main Results: Patients with unilateral community-acquired pneumonia demonstrated elevated concentrations of FVIIa, soluble TF, and thrombin-antithrombin complexes in bronchoalveolar lavage fluid obtained from the infected site compared with the uninfected site. Mice with S. pneumoniae pneumonia displayed increased TF expression and fibrin deposits in lungs together with elevated thrombin-antithrombin complex levels in bronchoalveolar lavage fluid; inhibition of TF-FVIIa by rNAPc2 attenuated the procoagulant response in the lung but did not affect host defense, as reflected by an unaltered outgrowth of pneumococci and an unchanged survival. Conclusions., These data suggest that TF-FVIIa activity contributes to activation of coagulation in the lung during pneumococcal pneumonia but does nut play an important role in the antibacterial host defense in this murine model.
引用
收藏
页码:1725 / 1730
页数:6
相关论文
共 43 条
[1]   Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].
Abraham, E ;
Reinhart, K ;
Opal, S ;
Demeyer, I ;
Doig, C ;
Rodriguez, AL ;
Beale, R ;
Svoboda, P ;
Laterre, PF ;
Simon, S ;
Light, B ;
Spapen, H ;
Stone, J ;
Seibert, A ;
Peckelsen, C ;
De Deyne, C ;
Postier, R ;
Pettilä, V ;
Sprung, CL ;
Artigas, A ;
Percell, SR ;
Shu, V ;
Zwingelstein, C ;
Tobias, J ;
Poole, L ;
Stolzenbach, JC ;
Creasey, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247
[2]   Coagulation abnormalities in acute lung injury and sepsis [J].
Abraham, E .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 22 (04) :401-404
[3]   Coagulation in sepsis [J].
Amaral, A ;
Opal, SM ;
Vincent, JL .
INTENSIVE CARE MEDICINE, 2004, 30 (06) :1032-1040
[4]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[5]   Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2 [J].
Bergum, PW ;
Cruikshank, A ;
Maki, SL ;
Kelly, CR ;
Ruf, W ;
Vlasuk, GP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :10063-10071
[6]   Tissue factor as a proinflammatory agent [J].
Bokarewa, MI ;
Morrissey, JH ;
Tarkowski, A .
ARTHRITIS RESEARCH, 2002, 4 (03) :190-195
[7]   Blockade of tissue factor - Treatment for organ injury in established sepsis [J].
Carraway, MS ;
Welty-Wolf, KE ;
Miller, DL ;
Ortel, TL ;
Idell, S ;
Ghio, AJ ;
Petersen, LC ;
Piantadosi, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (09) :1200-1209
[8]   Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection [J].
Choi, G ;
Schultz, MJ ;
van Till, JWO ;
Bresser, P ;
van der Zee, JS ;
Boermeester, MA ;
Levi, M ;
van der Poll, T .
EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (05) :786-789
[9]   TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK [J].
CREASEY, AA ;
CHANG, ACK ;
FEIGEN, L ;
WUN, TC ;
TAYLOR, FB ;
HINSHAW, LB .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2850-2860
[10]   Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia [J].
de Jonge, E ;
Dekkers, PEP ;
Creasey, AA ;
Hack, CE ;
Paulson, SK ;
Karim, A ;
Kesecioglu, J ;
Levi, M ;
van Deventer, SJH ;
van der Poll, T .
BLOOD, 2000, 95 (04) :1124-1129